Glycosylation of blood cells during the onset and progression of atherosclerosis and myocardial infarction.

[1]  Yoshiki Narimatsu,et al.  Direct observation of glycans bonded to proteins and lipids at single molecule level , 2023, Science.

[2]  M. Mayr,et al.  Proteomic Atlas of Atherosclerosis: The Contribution of Proteoglycans to Sex Differences, Plaque Phenotypes, and Outcomes , 2023, Circulation research.

[3]  L. Cerchia,et al.  Sialic Acids on Tumor Cells Modulate IgA Therapy by Neutrophils via Inhibitory Receptors Siglec-7 and Siglec-9 , 2023, Cancers.

[4]  B. Singla,et al.  Matricellular proteins in atherosclerosis development. , 2023, Matrix biology : journal of the International Society for Matrix Biology.

[5]  R. D. de Boer,et al.  Galectin-3 and Blood Group: Binding Properties, Effects on Plasma Levels, and Consequences for Prognostic Performance , 2023, International journal of molecular sciences.

[6]  G. Rabinovich,et al.  Targeting galectin-driven regulatory circuits in cancer and fibrosis , 2023, Nature Reviews Drug Discovery.

[7]  I. Gudelj,et al.  IgG N-Glycosylation Is Altered in Coronary Artery Disease , 2023, Biomolecules.

[8]  P. Libby,et al.  Fundamental Pathobiology of Coronary Atherosclerosis and Clinical Implications for Chronic Ischemic Heart Disease Management-The Plaque Hypothesis: A Narrative Review. , 2022, JAMA cardiology.

[9]  Markus M. Hilscher,et al.  Metabolic reprogramming and membrane glycan remodeling as potential drivers of zebrafish heart regeneration , 2022, Communications biology.

[10]  S. Stowell,et al.  ABO blood group antigens and differential glycan expression: Perspective on the evolution of common human enzyme deficiencies , 2022, iScience.

[11]  M. Telen,et al.  A Randomized Clinical Trial of the Efficacy and Safety of Rivipansel for Sickle Cell Vaso-occlusive Crisis (VOC). , 2022, Blood.

[12]  T. Cianciulli,et al.  Genetic Deletion of Galectin-3 Exacerbates Age-Related Myocardial Hypertrophy and Fibrosis in Mice. , 2022, Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology.

[13]  G. Lauc,et al.  Immunoglobulin G glycans - biomarkers and molecular effectors of aging. , 2022, Clinica chimica acta; international journal of clinical chemistry.

[14]  Chengcheng Liao,et al.  CD44 Glycosylation as a Therapeutic Target in Oncology , 2022, Frontiers in Oncology.

[15]  R. Spelat,et al.  Understanding How Heart Metabolic Derangement Shows Differential Stage Specificity for Heart Failure with Preserved and Reduced Ejection Fraction , 2022, Biomolecules.

[16]  A. Saviano,et al.  Galectin-9 supports primary T cell transendothelial migration in a glycan and integrin dependent manner. , 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[17]  N. Karlsson,et al.  Reproducing extracellular matrix adverse remodelling of non-ST myocardial infarction in a large animal model , 2022, bioRxiv.

[18]  H. Clausen,et al.  Applying transcriptomics to studyglycosylation at the cell type level , 2022, iScience.

[19]  G. Rabinovich,et al.  Galectin-1 prevents pathological vascular remodeling in atherosclerosis and abdominal aortic aneurysm , 2022, Science advances.

[20]  G. Beznoussenko,et al.  Opinion: On the Way towards the New Paradigm of Atherosclerosis , 2022, International journal of molecular sciences.

[21]  Jack C. Tang,et al.  Membrane Cholesterol Enrichment of Red Blood Cell-Derived Microparticles Results in Prolonged Circulation. , 2022, ACS applied bio materials.

[22]  L. Beckers,et al.  Anti-Galectin-2 Antibody Treatment Reduces Atherosclerotic Plaque Size and Alters Macrophage Polarity , 2021, Thrombosis and Haemostasis.

[23]  Hongzhou Guo,et al.  GALNT4 primes monocytes adhesion and transmigration by regulating O-Glycosylation of PSGL-1 in atherosclerosis. , 2021, Journal of molecular and cellular cardiology.

[24]  Shouqin Lü,et al.  Distinct binding kinetics of E‐, P‐ and L‐selectins to CD44 , 2021, The FEBS journal.

[25]  E. Zenteno,et al.  An Overview of Glycosylation and its Impact on Cardiovascular Health and Disease , 2021, Frontiers in Molecular Biosciences.

[26]  T. Gloster,et al.  Sialidase and Sialyltransferase Inhibitors: Targeting Pathogenicity and Disease , 2021, Frontiers in Molecular Biosciences.

[27]  E. Bourdon,et al.  Erythrocytes: Central Actors in Multiple Scenes of Atherosclerosis , 2021, International journal of molecular sciences.

[28]  R. Holmdahl,et al.  Emerging glyco‐based strategies to steer immune responses , 2021, The FEBS journal.

[29]  A. Dell,et al.  Red blood cell mannoses as phagocytic ligands mediating both sickle cell anaemia and malaria resistance , 2021, Nature Communications.

[30]  Rebekah L. Gundry,et al.  Characterization and statistical modeling of glycosylation changes in sickle cell disease. , 2021, Blood advances.

[31]  C. Bertozzi,et al.  The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans , 2021, Nature Reviews Drug Discovery.

[32]  P. Khunkaewla,et al.  Discrimination between minimally modified LDL and fully oxidized LDL using monoclonal antibodies. , 2021, Analytical biochemistry.

[33]  P. Crocker,et al.  Siglec-E retards atherosclerosis by inhibiting CD36-mediated foam cell formation , 2021, Journal of Biomedical Science.

[34]  M. Schwaiger,et al.  Imaging atherosclerotic plaques by targeting Galectin-3 and activated macrophages using (89Zr)-DFO- Galectin3-F(ab')2 mAb , 2021, Theranostics.

[35]  K. Yarema,et al.  Improving the Pharmacodynamics and In Vivo Activity of ENPP1‐Fc Through Protein and Glycosylation Engineering , 2020, Clinical and translational science.

[36]  G. Norata,et al.  Impact of Protein Glycosylation on Lipoprotein Metabolism and Atherosclerosis. , 2020, Cardiovascular research.

[37]  J. Wautier,et al.  Cellular and Molecular Aspects of Blood Cell–Endothelium Interactions in Vascular Disorders , 2020, International journal of molecular sciences.

[38]  L. T. ’t Hart,et al.  Metformin and statin use associate with plasma protein N-glycosylation in people with type 2 diabetes , 2020, BMJ open diabetes research & care.

[39]  Ting Zhao,et al.  Site-specific N-glycoproteme Analysis Reveals Up-regulated Sialylation and Core Fucosylation during Transient Regeneration Loss in Neonatal Mouse Hearts. , 2020, Journal of proteome research.

[40]  S. Sharma,et al.  Monocyte CD36 expression associates with atherosclerotic burden in diabetes mellitus. , 2020, Diabetes research and clinical practice.

[41]  S. Litovsky,et al.  Assessment of ICAM-1 N-glycoforms in mouse and human models of endothelial dysfunction , 2020, PloS one.

[42]  Shannon N. Conley,et al.  Digging Deeper into Precision/Personalized Medicine: Cracking the Sugar Code, the Third Alphabet of Life, and Sociomateriality of the Cell. , 2020, Omics : a journal of integrative biology.

[43]  M. Perola,et al.  Plasma N-Glycans as Emerging Biomarkers of Cardiometabolic Risk: A Prospective Investigation in the EPIC-Potsdam Cohort Study , 2020, Diabetes Care.

[44]  A. Varki,et al.  Decreased erythrocyte binding of Siglec-9 increases neutrophil activation in sickle cell disease. , 2019, Blood cells, molecules & diseases.

[45]  Richard G. Lee,et al.  ApoC-III Glycoforms Are Differentially Cleared by Hepatic TRL (Triglyceride-Rich Lipoprotein) Receptors. , 2019, Arteriosclerosis, thrombosis, and vascular biology.

[46]  D. Gaudet,et al.  Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome. , 2019, The New England journal of medicine.

[47]  R. Schiffelers,et al.  Red Blood Cells: Chasing Interactions , 2019, Front. Physiol..

[48]  C. Weber,et al.  Glycans and Glycan-Binding Proteins in Atherosclerosis , 2019, Thrombosis and Haemostasis.

[49]  T. Kubota,et al.  Red blood cells participate in reverse cholesterol transport by mediating cholesterol efflux of high-density lipoprotein and apolipoprotein A-I from THP-1 macrophages , 2019, Biological chemistry.

[50]  H. Lauridsen,et al.  Myocardial infarction and the immune response - Scarring or regeneration? A comparative look at mammals and popular regenerating animal models , 2019, Journal of Immunology and Regenerative Medicine.

[51]  G. Lykotrafitis,et al.  Valsartan impedes epinephrine-induced ICAM-4 activation on normal, sickle cell trait and sickle cell disease red blood cells , 2019, PloS one.

[52]  A. Orekhov,et al.  Glycosylation of human plasma lipoproteins reveals a high level of diversity, which directly impacts their functional properties. , 2019, Biochimica et biophysica acta. Molecular and cell biology of lipids.

[53]  T. Münzel,et al.  Lysed Erythrocyte Membranes Promote Vascular Calcification: Possible Role of Erythrocyte-Derived Nitric Oxide , 2019, Circulation.

[54]  J. Novak,et al.  Glycosylation in health and disease , 2019, Nature Reviews Nephrology.

[55]  M. Bryckaert,et al.  Relevance of platelet desialylation and thrombocytopenia in type 2B von Willebrand disease: preclinical and clinical evidence , 2019, Haematologica.

[56]  R. Alon,et al.  Distinct Compartmentalization of the Chemokines CXCL1 and CXCL2 and the Atypical Receptor ACKR1 Determine Discrete Stages of Neutrophil Diapedesis , 2018, Immunity.

[57]  K. Linton,et al.  Identification of CD36 as a new interaction partner of membrane NEU1: potential implication in the pro-atherogenic effects of the elastin receptor complex , 2018, Cellular and Molecular Life Sciences.

[58]  Kiyoko F. Aoki-Kinoshita,et al.  Systems glycomics of adult zebrafish identifies organ-specific sialylation and glycosylation patterns , 2018, Nature Communications.

[59]  G. Rabinovich,et al.  Galectin-1 as an Emerging Mediator of Cardiovascular Inflammation: Mechanisms and Therapeutic Opportunities , 2018, Mediators of inflammation.

[60]  B. Moerschbacher,et al.  The endothelial glycocalyx anchors von Willebrand factor fibers to the vascular endothelium. , 2018, Blood advances.

[61]  A. Fox-Robichaud,et al.  Sialidase down-regulation reduces non-HDL cholesterol, inhibits leukocyte transmigration, and attenuates atherosclerosis in ApoE knockout mice , 2018, The Journal of Biological Chemistry.

[62]  P. Wei,et al.  Galectin-1 Restricts Vascular Smooth Muscle Cell Motility Via Modulating Adhesion Force and Focal Adhesion Dynamics , 2018, Scientific Reports.

[63]  R. Sackstein,et al.  Ligation of the CD44 Glycoform HCELL on Culture-Expanded Human Monocyte-Derived Dendritic Cells Programs Transendothelial Migration , 2018, The Journal of Immunology.

[64]  Abhay Pandit,et al.  Implantation of hyaluronic acid hydrogel prevents the pain phenotype in a rat model of intervertebral disc injury , 2018, Science Advances.

[65]  G. Minetti,et al.  Continuous Change in Membrane and Membrane-Skeleton Organization During Development From Proerythroblast to Senescent Red Blood Cell , 2018, Front. Physiol..

[66]  N. Seidah,et al.  Site-specific O-glycosylation of members of the low-density lipoprotein receptor superfamily enhances ligand interactions , 2018, The Journal of Biological Chemistry.

[67]  David C. Zhu,et al.  Effects of Nanoprobe Morphology on Cellular Binding and Inflammatory Responses: Hyaluronan-Conjugated Magnetic Nanoworms for Magnetic Resonance Imaging of Atherosclerotic Plaques. , 2018, ACS applied materials & interfaces.

[68]  T. Spector,et al.  Glycosylation Profile of Immunoglobulin G Is Cross-Sectionally Associated With Cardiovascular Disease Risk Score and Subclinical Atherosclerosis in Two Independent Cohorts , 2018, Circulation research.

[69]  T. K. van den Berg,et al.  Glycophorin-C sialylation regulates Lu/BCAM adhesive capacity during erythrocyte aging. , 2018, Blood advances.

[70]  Khoa Nguyen,et al.  Targeted Measurements of O- and N-Glycopeptides Show That Proteins in High Density Lipoprotein Particles Are Enriched with Specific Glycosylation Compared to Plasma. , 2017, Journal of proteome research.

[71]  Honglin Li,et al.  Functional Metabolomics Characterizes a Key Role for N-Acetylneuraminic Acid in Coronary Artery Diseases , 2017, Circulation.

[72]  A. Orekhov,et al.  Chemical composition of circulating native and desialylated low density lipoprotein: what is the difference? , 2017 .

[73]  S. Stowell,et al.  Expression of Lewis‐a glycans on polymorphonuclear leukocytes augments function by increasing transmigration , 2017, Journal of leukocyte biology.

[74]  H. Niessen,et al.  Stasis Promotes Erythrocyte Adhesion to von Willebrand Factor , 2017, Arteriosclerosis, thrombosis, and vascular biology.

[75]  E. Monti,et al.  Contribution of vascular endothelial growth factor receptor-2 sialylation to the process of angiogenesis , 2017, Oncogene.

[76]  J. Michel,et al.  Erythrocyte Efferocytosis by the Arterial Wall Promotes Oxidation in Early-Stage Atheroma in Humans , 2017, Front. Cardiovasc. Med..

[77]  V. Nizet,et al.  Erythrocyte sialoglycoproteins engage Siglec-9 on neutrophils to suppress activation. , 2017, Blood.

[78]  Caroline E Burns,et al.  Zebrafish heart regeneration: 15 years of discoveries , 2017, Regeneration.

[79]  Jian Li,et al.  Modified citrus pectin inhibits galectin-3 function to reduce atherosclerotic lesions in apoE-deficient mice , 2017, Molecular medicine reports.

[80]  Jiao Guo,et al.  Downregulations of CD36 and Calpain-1, Inflammation, and Atherosclerosis by Simvastatin in Apolipoprotein E Knockout Mice , 2017, Journal of Vascular Research.

[81]  M. Woodward,et al.  Plasma and blood viscosity in the prediction of cardiovascular disease and mortality in the Scottish Heart Health Extended Cohort Study , 2017, European journal of preventive cardiology.

[82]  A. Orekhov,et al.  Carbohydrate composition of circulating multiple-modified low-density lipoprotein , 2016, Vascular health and risk management.

[83]  N. Packer,et al.  Emerging roles of protein mannosylation in inflammation and infection. , 2016, Molecular aspects of medicine.

[84]  R. Weissleder,et al.  E-Selectin Inhibition Mitigates Splenic HSC Activation and Myelopoiesis in Hypercholesterolemic Mice With Myocardial Infarction , 2016, Arteriosclerosis, thrombosis, and vascular biology.

[85]  S. Sarnaik,et al.  VLA‐4 blockade by natalizumab inhibits sickle reticulocyte and leucocyte adhesion during simulated blood flow , 2016, British journal of haematology.

[86]  C. Lebrilla,et al.  Combined High-Density Lipoprotein Proteomic and Glycomic Profiles in Patients at Risk for Coronary Artery Disease. , 2015, Journal of proteome research.

[87]  B. Aronow,et al.  Red Blood Cell Dysfunction Induced by High-Fat Diet: Potential Implications for Obesity-Related Atherosclerosis. , 2015, Circulation.

[88]  O. Suzuki,et al.  Sialylation and glycosylation modulate cell adhesion and invasion to extracellular matrix in human malignant lymphoma: Dependency on integrin and the Rho GTPase family , 2015, International journal of oncology.

[89]  Qing Liu,et al.  Lewis Y antigen modified CD47 is an independent risk factor for poor prognosis and promotes early ovarian cancer metastasis. , 2015, American journal of cancer research.

[90]  S. Mousa,et al.  Oxidized low-density lipoprotein as a biomarker of cardiovascular diseases , 2015, Critical reviews in clinical laboratory sciences.

[91]  G. Sloop,et al.  Perspective The failure of cholesteryl ester transfer protein inhibitors: is it due to increased blood viscosity? , 2015, Therapeutic advances in cardiovascular disease.

[92]  O. Campetella,et al.  Galectin-8 elicits pro-inflammatory activities in the endothelium. , 2014, Glycobiology.

[93]  Pushpankur Ghoshal,et al.  Glycosylation Inhibitors Efficiently Inhibit P-Selectin-Mediated Cell Adhesion to Endothelial Cells , 2014, PloS one.

[94]  Jacquelyn N. Tomaio,et al.  Trauma-Hemorrhagic Shock Induces a CD36-Dependent RBC Endothelial-Adhesive Phenotype , 2014, Critical care medicine.

[95]  P. Münzer,et al.  Dynamic adhesion of eryptotic erythrocytes to immobilized platelets via platelet phosphatidylserine receptors. , 2014, American journal of physiology. Cell physiology.

[96]  Chuan-Fa Chang,et al.  Recombinant Lectin-Like Domain of Thrombomodulin Suppresses Vascular Inflammation by Reducing Leukocyte Recruitment via Interacting With Lewis Y on Endothelial Cells , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[97]  Mark R. Miller,et al.  Inhibition of galectin-3 reduces atherosclerosis in apolipoprotein E-deficient mice. , 2013, Glycobiology.

[98]  Bertram Pitt,et al.  Genetic and Pharmacological Inhibition of Galectin-3 Prevents Cardiac Remodeling by Interfering With Myocardial Fibrogenesis , 2013, Circulation. Heart failure.

[99]  M. Telen,et al.  Effect of Propranolol as Antiadhesive Therapy in Sickle Cell Disease , 2012, Clinical and translational science.

[100]  A. Duits,et al.  N-acetylcysteine reduces oxidative stress in sickle cell patients , 2012, Annals of Hematology.

[101]  A. Markowska,et al.  Galectin-3 Protein Modulates Cell Surface Expression and Activation of Vascular Endothelial Growth Factor Receptor 2 in Human Endothelial Cells* , 2011, The Journal of Biological Chemistry.

[102]  D. Tziakas,et al.  Erythrocyte Duffy antigen receptor for chemokines (DARC): diagnostic and therapeutic implications in atherosclerotic cardiovascular disease , 2011, Acta Pharmacologica Sinica.

[103]  Q. Xu.  The Indian blood group system , 2011, Immunohematology.

[104]  J. Elion,et al.  Activation State of α4β1 Integrin on Sickle Red Blood Cells Is Linked to the Duffy Antigen Receptor for Chemokines (DARC) Expression* , 2010, The Journal of Biological Chemistry.

[105]  J. Wakefield,et al.  Proteolytic Shedding of ST6Gal-I by BACE1 Regulates the Glycosylation and Function of α4β1 Integrins* , 2008, Journal of Biological Chemistry.

[106]  M. Telen,et al.  Role and regulation of sickle red cell interactions with other cells: ICAM-4 and other adhesion receptors. , 2008, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine.

[107]  M. Czerwinski,et al.  Mutational analysis of the N-glycosylation sites of Duffy antigen/receptor for chemokines. , 2007, Biochemical and biophysical research communications.

[108]  C. Cotorruelo,et al.  Effect of membrane-bound IgG and desialysation in the interaction of monocytes with senescent erythrocytes , 2006, Clinical and Experimental Medicine.

[109]  P. Gane,et al.  Integrin receptor specificity for human red cell ICAM-4 ligand. Critical residues for alphaIIbeta3 binding. , 2004, European journal of biochemistry.

[110]  Yusuke Nakamura,et al.  Functional variation in LGALS2 confers risk of myocardial infarction and regulates lymphotoxin-α secretion in vitro , 2004, Nature.

[111]  A. Nandi,et al.  Bimolecular complex between rolling and firm adhesion receptors required for cell arrest; CD44 association with VLA-4 in T cell extravasation. , 2004, Immunity.

[112]  N. Mohandas,et al.  Identification of critical amino-acid residues on the erythroid intercellular adhesion molecule-4 (ICAM-4) mediating adhesion to alpha V integrins. , 2004, Blood.

[113]  M. Krieger,et al.  Identification of the N-Linked Glycosylation Sites on the High Density Lipoprotein (HDL) Receptor SR-BI and Assessment of Their Effects on HDL Binding and Selective Lipid Uptake* , 2003, The Journal of Biological Chemistry.

[114]  B. Setty,et al.  Role of erythrocyte phosphatidylserine in sickle red cell-endothelial adhesion. , 2002, Blood.

[115]  M. Bergeron,et al.  Role of Galectin-3 as an Adhesion Molecule for Neutrophil Extravasation During Streptococcal Pneumonia1 , 2002, The Journal of Immunology.

[116]  K. Kikugawa,et al.  Recognition of sialosaccharide chains of glycophorin on damaged erythrocytes by macrophage scavenger receptors. , 1995, Biochimica et biophysica acta.

[117]  A. Fiorilli,et al.  Human erythrocyte sialidase is linked to the plasma membrane by a glycosylphosphatidylinositol anchor and partly located on the outer surface , 1993, Glycoconjugate Journal.

[118]  OUP accepted manuscript , 2021, Glycobiology.

[119]  Bradley W Ellis,et al.  Distinct glycosylation in membrane proteins within neonatal versus adult myocardial tissue. , 2019, Matrix biology : journal of the International Society for Matrix Biology.

[120]  A. Griffioen,et al.  Examination of the role of galectins and galectin inhibitors in endothelial cell biology. , 2015, Methods in molecular biology.

[121]  A. Varki,et al.  Biological Functions of Glycans , 2015 .

[122]  G. Rabinovich,et al.  Galectin-1 controls cardiac inflammation and ventricular remodeling during acute myocardial infarction. , 2013, The American journal of pathology.

[123]  Carolyn R. Bertozzi,et al.  Glycans in Biotechnology and the Pharmaceutical Industry , 2009 .

[124]  C. Bertozzi,et al.  Chemical Tools for Inhibiting Glycosylation , 2009 .

[125]  M. Telen.  Erythrocyte adhesion receptors: blood group antigens and related molecules. , 2005, Transfusion medicine reviews.

[126]  F. Park,et al.  CD47 Activation by Thrombospondin-1 in Lymphatic Endothelial Cells Suppresses Lymphangiogenesis and Promotes Atherosclerosis , 2023, Arteriosclerosis, thrombosis, and vascular biology.